What is Fulgent Genetics, Inc.'s D&A?

Fulgent Genetics, Inc. (FLGT) reported D&A of $6M in Q1 2026.

How has Fulgent Genetics, Inc.'s D&A changed year-over-year?

Fulgent Genetics, Inc.'s D&A increased by 1.4% year-over-year, from $5.92M to $6M.

What is the long-term trend for Fulgent Genetics, Inc.'s D&A?

Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s D&A has grown at a 21.7% compound annual growth rate (CAGR), from $11M to $24.12M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Fulgent Genetics, Inc. FLGT D&A

D&A at other companies

Bristol-Myers SquibbBMY

$594M-41.3%

Labcorp HoldingsLH

$173.3M+3.9%

Quest DiagnosticsDGX

$147M+5.0%

NeoGenomicsNEO

$8.78M-6.3%

Natera, Inc.NTRA

$14.52M+57.2%

GeneDx HoldingsWGS

$6.81M+19.9%

Segments

By segment

See full

Laboratory Services$5.86M+1.8%

Therapeutic Development$143K-12.8%

Other financials

Income statement

See full

Revenue$71.1M-3.2%

Gross profit$21.5M-24.2%

Operating income-$34.6M-74.9%

Net income-$24.8M-115%

EPS (diluted)-$0.80-116%

Balance sheet

See full

Cash & equivalents$23.4M-65.2%

Total debt$8.2M+40.5%

Total equity$1.0B-6.9%

Total assets$1.2B-4.1%

Cash flow

See full

Operating cash flow$7.1M+260%

CapEx$5.2M+10.3%

Free cash flow$1.9M+121%

Valuation

See full

Market cap$552.11M-7.1%

Enterprise value$536.92M+0.7%

P/S1.7×-0.3×

Profitability

See full

Gross margin38.7%-0.1pp

Operating margin-33.1%+17.4pp

Net margin-23%+43.3pp

FCF margin-36.9%—

Returns & leverage

See full

Return on equity-6.8%+48.2pp

Debt / equity0×0.0×

Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s D&A?: Fulgent Genetics, Inc. (FLGT) reported D&A of $6M in Q1 2026.
How has Fulgent Genetics, Inc.'s D&A changed year-over-year?: Fulgent Genetics, Inc.'s D&A increased by 1.4% year-over-year, from $5.92M to $6M.
What is the long-term trend for Fulgent Genetics, Inc.'s D&A?: Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s D&A has grown at a 21.7% compound annual growth rate (CAGR), from $11M to $24.12M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.